Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Articolo
Data di Pubblicazione:
2011
Citazione:
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial / Viale G, 1. 7. 7.; Regan, Mm; Dell’Orto, P; Mastropasqua, Mg; Maiorano, Eugenio; Rasmussen, Bb; Macgrogan, G; Forbes, Jf; Paridaens, Rj; Colleoni, M; Làng, I; Thurlimann, ; Mouridsen, H; Mauriac, L; Gelber, Rd; Price, Kn; Goldhirsch, A; Gusterson, Ba; Coates, As. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 22:10(2011), pp. 2201-2207. [10.1093/annonc/mdq738]
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Breast cancer; Therapy; clinical trial
Elenco autori:
Viale G, 1. 7. 7.; Regan, Mm; Dell’Orto, P; Mastropasqua, Mg; Maiorano, Eugenio; Rasmussen, Bb; Macgrogan, G; Forbes, Jf; Paridaens, Rj; Colleoni, M; Làng, I; Thurlimann, ; Mouridsen, H; Mauriac, L; Gelber, Rd; Price, Kn; Goldhirsch, A; Gusterson, Ba; Coates, As
Link alla scheda completa:
Pubblicato in: